Wait.. So now they consider it a "Covid drug" and the people that have been saying for DECADES that it can possibly treat cancer may be RIGHT? Too bad you can't paten it huh pharma bros.
Archive: https://archive.today/lPtSA
From the post:
>A controversial anti-worming drug that was thrust into the spotlight during the Covid-19 pandemic after right-leaning doctor groups promoted unfounded claims that it cured the virus is now under scrutiny for its potential to treat cancer.
Ivermectin, a drug that treats parasitic infections in people and livestock, is the latest focus at the National Cancer Institute, the world’s preeminent cancer research center that is part of the National Institutes of Health.
The NCI, headed by President Donald Trump appointee Dr Anthony Letai, did not cite new evidence to support this hypothesis when he announced the new endeavor.
‘There are enough reports of it, enough interest in it, that we actually did — ivermectin, in particular — did engage in sort of a better preclinical study of its properties and its ability to kill cancer cells,’ Letai said at a January event with NIH Director Jay Bhattacharya and other senior agency officials.
Wait.. So now they consider it a "Covid drug" and the people that have been saying for DECADES that it can possibly treat cancer may be RIGHT? Too bad you can't paten it huh pharma bros.
Archive: https://archive.today/lPtSA
From the post:
>>A controversial anti-worming drug that was thrust into the spotlight during the Covid-19 pandemic after right-leaning doctor groups promoted unfounded claims that it cured the virus is now under scrutiny for its potential to treat cancer.
Ivermectin, a drug that treats parasitic infections in people and livestock, is the latest focus at the National Cancer Institute, the world’s preeminent cancer research center that is part of the National Institutes of Health.
The NCI, headed by President Donald Trump appointee Dr Anthony Letai, did not cite new evidence to support this hypothesis when he announced the new endeavor.
‘There are enough reports of it, enough interest in it, that we actually did — ivermectin, in particular — did engage in sort of a better preclinical study of its properties and its ability to kill cancer cells,’ Letai said at a January event with NIH Director Jay Bhattacharya and other senior agency officials.